Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Bioceres Crop Solutions (BIOX) over the last 8 years, with Q3 2025 value amounting to -$14.3 million.

  • Bioceres Crop Solutions' Net Cash Flow fell 506.98% to -$14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year decrease of 9020.7%. This contributed to the annual value of -$6.9 million for FY2025, which is 33629.9% down from last year.
  • According to the latest figures from Q3 2025, Bioceres Crop Solutions' Net Cash Flow is -$14.3 million, which was down 506.98% from $2.5 million recorded in Q2 2025.
  • Bioceres Crop Solutions' 5-year Net Cash Flow high stood at $28.3 million for Q2 2024, and its period low was -$14.3 million during Q3 2025.
  • Over the past 5 years, Bioceres Crop Solutions' median Net Cash Flow value was $1.8 million (recorded in 2021), while the average stood at $2.4 million.
  • In the last 5 years, Bioceres Crop Solutions' Net Cash Flow soared by 320286.52% in 2022 and then tumbled by 43210.34% in 2023.
  • Quarter analysis of 5 years shows Bioceres Crop Solutions' Net Cash Flow stood at $580198.0 in 2021, then skyrocketed by 3202.87% to $19.2 million in 2022, then grew by 13.84% to $21.8 million in 2023, then tumbled by 70.27% to $6.5 million in 2024, then plummeted by 320.99% to -$14.3 million in 2025.
  • Its last three reported values are -$14.3 million in Q3 2025, $2.5 million for Q2 2025, and $8.1 million during Q1 2025.